Market Overview

UPDATE: JP Morgan Downgrades Health Care REIT to Overweight on Valuation

Share:
Related HCN
BMO Capital's John Kim Explains Why Ventas Is A Healthcare REIT Worth Watching
Buy Healthcare REITs, It's The Best Time To Do It In 18 Months: Canaccord
Health Care REIT's (HCN) Q2 Earnings: Will it Surprise? - Analyst Blog (Zacks)

JP Morgan downgraded Health Care REIT (NYSE: HCN) from Overweight to Neutral and maintained a $63.00 price target.

JP Morgan noted, "We are downgrading HCN to Neutral from Overweight. This call is a relative stock call as we continue to view the fundamental prospects and growth outlook for HCN favorably. We simply hold a bias toward more economically leveraged property types at this time and see near-term catalysts elsewhere in the REIT sector. … HCN trades at 15.9x our 2013 FFO estimate, a 3% premium to the healthcare group average."

Health Care REIT closed at $61.31 on Tuesday.

Latest Ratings for HCN

DateFirmActionFromTo
Jul 2015SunTrust Robinson HumphreyInitiates Coverage onBuy
Jul 2015CitigroupMaintainsNeutral
Jun 2015Evercore PartnersUpgradesHoldBuy

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (HCN)

Get Benzinga's Newsletters